Document is current
Any future updates will be listed below
-
Authors
Yang, Yiling
Wang, Ruoke
Guo, Fenglin
Zhao, Tian
Lei, Yuqing
Yang, Qianqian
Zeng, Yige
Yang, Ziqing
Ajavavarakula, Tatchapon
Tan, Ruijie
Li, Mingxi
Dong, Haodi
Niu, Mengyue
Bao, Keyan
Geng, Hao
Lv, Qining
Zhang, Qi
Shi, Xuanling
Liu, Peng
Ge, Jiwan
Wang, Xinquan
Zhang, Linqi
-
Funding
Funding for this research was provided by:
National Key Plan for Scientific Research and Development of China (2022YFF1203100, 2022YFF1203100, 2021YFC2300104, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2022YFF1203100, 2021YFC2300104, 2022YFF1203100)
National Natural Science Foundation (92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205, 92169205)
Wanke Scientific Research Program (20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056, 20221080056)
Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2023-RC180-01)
- License Information
-
More Information
Article History
Received: 29 September 2024
Accepted: 25 December 2024
First Online: 31 December 2024
Competing interests
: Patent application has been filed on a highly neutralizing antibody targeting RSV. L.Z., Y.Y., X.S. and Q.Z. are the inventors. The remaining authors declare no competing interests.
